WDR5B

gene
On this page

Also known as FLJ11287

Summary

WDR5B (WD repeat domain 5B, HGNC:17826) is a protein-coding gene on chromosome 3q21.1, encoding WD repeat-containing protein 5B (Q86VZ2). Plays a role in the proliferation of retinal pigment epithelial (RPE) cells.

This intronless gene encodes a protein containing several WD40 repeats. WD repeats are approximately 30- to 40-amino acid domains containing several conserved residues, including a trp-asp at the C-terminal end. The encoded protein may mediate protein-protein interactions.

Source: NCBI Gene 54554 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 40 total
  • MANE Select transcript: NM_019069

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17826
Approved symbolWDR5B
NameWD repeat domain 5B
Location3q21.1
Locus typegene with protein product
StatusApproved
AliasesFLJ11287
Ensembl geneENSG00000196981
Ensembl biotypeprotein_coding
OMIM621240
Entrez54554

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000330689, ENST00000920957

RefSeq mRNA: 1 — MANE Select: NM_019069 NM_019069

CCDS: CCDS3012

Canonical transcript exons

ENST00000330689 — 1 exons

ExonStartEnd
ENSE00001293682122411846122416062

Expression profiles

Bgee: expression breadth ubiquitous, 220 present calls, max score 83.52.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.2142 / max 69.9609, expressed in 1686 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
441287.21421686

Top tissues by expression

267 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bronchial epithelial cellCL:000232883.52gold quality
epithelium of bronchusUBERON:000203183.37gold quality
epithelium of nasopharynxUBERON:000195183.01gold quality
right uterine tubeUBERON:000130282.97gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.18gold quality
bronchusUBERON:000218582.02gold quality
hair follicleUBERON:000207379.85silver quality
diaphragmUBERON:000110377.08gold quality
islet of LangerhansUBERON:000000676.57gold quality
body of pancreasUBERON:000115076.37gold quality
corpus epididymisUBERON:000435976.32gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047375.44gold quality
pancreasUBERON:000126475.17gold quality
calcaneal tendonUBERON:000370175.16gold quality
tibiaUBERON:000097974.74gold quality
caput epididymisUBERON:000435874.68gold quality
parotid glandUBERON:000183174.44silver quality
monocyteCL:000057674.40gold quality
leukocyteCL:000073874.32gold quality
mononuclear cellCL:000084274.18gold quality
ventricular zoneUBERON:000305373.88gold quality
right lobe of liverUBERON:000111473.79gold quality
right adrenal glandUBERON:000123373.62gold quality
stromal cell of endometriumCL:000225573.56gold quality
right adrenal gland cortexUBERON:003582773.53gold quality
endometriumUBERON:000129573.33gold quality
ganglionic eminenceUBERON:000402373.15gold quality
granulocyteCL:000009473.14gold quality
germinal epithelium of ovaryUBERON:000130473.13gold quality
mucosa of paranasal sinusUBERON:000503073.04gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-100618yes660.86
E-ANND-3yes3.74

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

90 targeting WDR5B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-8485100.0077.574731
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-126-5P100.0072.713180
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-428299.9975.366408
HSA-MIR-186-5P99.9970.833707
HSA-MIR-150-5P99.9966.691976
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-806899.9873.852376
HSA-MIR-512-3P99.9767.351049
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-302E99.9670.742669
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-3682-5P99.9367.971163
HSA-MIR-381-3P99.9371.872854
HSA-MIR-30099.9271.762856
HSA-MIR-329-3P99.9166.561234
HSA-MIR-362-3P99.9166.381267
HSA-MIR-130599.9171.433443
HSA-MIR-589-3P99.9169.622088
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-302A-3P99.8971.231777
HSA-MIR-302B-3P99.8971.231777
HSA-MIR-302C-3P99.8971.201778
HSA-MIR-302D-3P99.8971.251777

Literature-anchored findings (GeneRIF, showing 1)

  • Initial Characterization of WDR5B Reveals a Role in the Proliferation of Retinal Pigment Epithelial Cells. (PMID:39056772)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriowdr5ENSDARG00000016903
mus_musculusWdr5bENSMUSG00000034379
rattus_norvegicusWdr5bENSRNOG00000002253
drosophila_melanogasterCG10931FBGN0034274
drosophila_melanogasterwdsFBGN0040066

Paralogs (26): PAFAH1B1 (ENSG00000007168), SNRNP40 (ENSG00000060688), WDR62 (ENSG00000075702), WDR7 (ENSG00000091157), TBL2 (ENSG00000106638), PAK1IP1 (ENSG00000111845), WDR75 (ENSG00000115368), DCAF4 (ENSG00000119599), DAW1 (ENSG00000123977), TEP1 (ENSG00000129566), AHI1 (ENSG00000135541), WDR38 (ENSG00000136918), MAPKBP1 (ENSG00000137802), POC1B (ENSG00000139323), NEDD1 (ENSG00000139350), COP1 (ENSG00000143207), WDR17 (ENSG00000150627), WDR43 (ENSG00000163811), POC1A (ENSG00000164087), WDR88 (ENSG00000166359), WDR81 (ENSG00000167716), DCAF4L2 (ENSG00000176566), DCAF4L1 (ENSG00000182308), WDR27 (ENSG00000184465), NWD1 (ENSG00000188039), WDR5 (ENSG00000196363)

Protein

Protein identifiers

WD repeat-containing protein 5BQ86VZ2 (reviewed: Q86VZ2)

All UniProt accessions (1): Q86VZ2

UniProt curated annotations — full annotation on UniProt →

Function. Plays a role in the proliferation of retinal pigment epithelial (RPE) cells. May function as a substrate receptor for CUL4-DDB1 ubiquitin E3 ligase complex.

Subunit / interactions. Probable part of a cullin-RING E3 protein ligase complex containing CUL4B-DDB1 and a substrate-recruiting component (DCAF). Interacts with CUL4B and DDB1.

Subcellular location. Nucleus.

Induction. Up-regulated upon neural differentiation.

Similarity. Belongs to the WD repeat WDR5/wds family.

RefSeq proteins (1): NP_061942* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001680WD40_rptRepeat
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR019775WD40_repeat_CSConserved_site
IPR020472WD40_PAC1Repeat
IPR036322WD40_repeat_dom_sfHomologous_superfamily
IPR059122Beta-prop_WDR5-likeDomain

Pfam: PF25175

UniProt features (13 total): repeat 7, compositionally biased region 2, chain 1, sequence conflict 1, region of interest 1, short sequence motif 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86VZ2-F193.360.90

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 78 (showing top): BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, HAND1E47_01, chr3q21, TGGAAA_NFAT_Q4_01, GOCC_TRANSFERASE_COMPLEX, GOCC_SET1C_COMPASS_COMPLEX, GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX, GOCC_METHYLTRANSFERASE_COMPLEX, GOMF_HISTONE_BINDING, MARTENS_TRETINOIN_RESPONSE_UP, GATA1_05, BARX1_TARGET_GENES, DLX4_TARGET_GENES, DLX6_TARGET_GENES, ELF2_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (2): histone binding (GO:0042393), protein binding (GO:0005515)

GO Cellular Component (2): nucleus (GO:0005634), Set1C/COMPASS complex (GO:0048188)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein binding1
binding1
intracellular membrane-bounded organelle1
histone methyltransferase complex1

Protein interactions and networks

STRING

1668 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
WDR5BASH2LQ9UBL3435
WDR5BSAMD4BQ5PRF9406
WDR5BRBBP5Q15291404
WDR5BFAM162AQ96A26377
WDR5BMIX23Q4VC31376
WDR5BSMAGPQ0VAQ4359
WDR5BSEC22AQ96IW7351
WDR5BFOXP4Q8IVH2349
WDR5BDPY30Q9C005348
WDR5BCASKIN2Q8WXE0343
WDR5BANKRD22Q5VYY1333
WDR5BCNTLNQ9NXG0333
WDR5BGPRC5CQ9NQ84332
WDR5BFOXP2O15409330
WDR5BDPH7Q9BTV6329

IntAct

22 interactions, top by confidence:

ABTypeScore
ASH2LKMT2Dpsi-mi:“MI:0914”(association)0.890
KMT2DRBBP5psi-mi:“MI:0914”(association)0.840
RBBP5KMT2Dpsi-mi:“MI:0914”(association)0.840
CUL4BCUL4Apsi-mi:“MI:0914”(association)0.730
SNRNP27UBA6psi-mi:“MI:0914”(association)0.530
WDR5BTCP1psi-mi:“MI:0914”(association)0.530
ESR1KMT2Dpsi-mi:“MI:0914”(association)0.520
CFTRWDR5Bpsi-mi:“MI:0915”(physical association)0.370
WDR5BATP13A2psi-mi:“MI:0915”(physical association)0.370
WDR5BDDB1psi-mi:“MI:0914”(association)0.350
NUDT9WDR5Bpsi-mi:“MI:0914”(association)0.350
Ppsi-mi:“MI:0914”(association)0.350
DCAF4IGLL5psi-mi:“MI:0914”(association)0.350
GPIHBP1SAC3D1psi-mi:“MI:0914”(association)0.350
WDR5BHSPA8psi-mi:“MI:0914”(association)0.350
AFG2AESYT2psi-mi:“MI:0914”(association)0.350

BioGRID (280): RPIA (Affinity Capture-MS), WDR5B (Affinity Capture-MS), WDR5B (Affinity Capture-MS), RNF220 (Affinity Capture-MS), HSF2 (Affinity Capture-MS), SEPN1 (Affinity Capture-MS), CLTCL1 (Affinity Capture-MS), ZNRF2 (Affinity Capture-MS), CCT4 (Affinity Capture-MS), CCT2 (Affinity Capture-MS), CCT3 (Affinity Capture-MS), RRP12 (Affinity Capture-MS), CCT6B (Affinity Capture-MS), TCP1 (Affinity Capture-MS), CCT6A (Affinity Capture-MS)

ESM2 similar proteins: A0A2R8RWN9, A5GFZ5, A9L985, O19137, O42602, O42603, O60762, O70152, O77676, P00516, P0C605, P19969, P31504, P31505, P31644, P35250, P41227, P47866, P51006, P53033, Q01777, Q01789, Q02029, Q02030, Q02033, Q08E50, Q13976, Q16576, Q1JQ93, Q24572, Q2KI14, Q3SWX8, Q3UX61, Q4R304, Q5FVR7, Q5MB13, Q5R654, Q5RE95, Q60748, Q60973

Diamond homologs: A1CTE6, A1DMI8, A2QVV2, B0Y7H6, B8N4F5, C4R6H3, C4YFX2, D9N129, P0CY34, P16371, P16649, P56094, Q00664, Q08274, Q09019, Q0CKB1, Q10437, Q2HJH6, Q2UM42, Q4WN25, Q5M786, Q5RE95, Q5RF51, Q5SQM0, Q6ED65, Q6PE01, Q6ZMW3, Q86VZ2, Q96DI7, Q9P4R5, Q9SY00, Q9VBC4, A8X8C6, B6QC56, B8N9H4, C0S902, C1GB49, C5FWH1, C5GVJ9, C5JD40

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 21 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Neddylation513.9×5e-04

GO biological processes:

GO termPartnersFoldFDR
DNA damage response616.1×1e-04
protein ubiquitination510.3×4e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

40 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance37
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

128 predictions. Top by Δscore:

VariantEffectΔscore
3:122415943:A:ACdonor_gain0.9100
3:122415944:C:CCdonor_gain0.9100
3:122415608:A:Tacceptor_gain0.8500
3:122415940:G:Cdonor_gain0.8300
3:122415945:T:Cdonor_gain0.8300
3:122412693:C:CTacceptor_gain0.7900
3:122415938:TAGG:Tdonor_gain0.7600
3:122415923:CCCTA:Cdonor_loss0.7400
3:122415924:CCT:Cdonor_loss0.7400
3:122415925:CTA:Cdonor_loss0.7400
3:122415926:TA:Tdonor_loss0.7400
3:122415927:A:ATdonor_loss0.7400
3:122415928:C:Tdonor_loss0.7400
3:122415922:GCCCT:Gdonor_loss0.7100
3:122415929:C:Adonor_loss0.7100
3:122414746:ATTGG:Aacceptor_gain0.6900
3:122415458:T:TAdonor_gain0.6800
3:122415998:GAAGC:Gdonor_gain0.6500
3:122415928:CCAGT:Cdonor_gain0.6300
3:122414739:C:CCacceptor_gain0.6000
3:122416002:C:CTdonor_gain0.6000
3:122415927:A:ACdonor_gain0.5900
3:122415928:C:CCdonor_gain0.5900
3:122412753:ATCT:Aacceptor_gain0.5700
3:122414738:A:Cacceptor_gain0.5500
3:122414747:TTGGC:Tacceptor_gain0.5500
3:122415921:AGCC:Adonor_loss0.5500
3:122415997:CGAAG:Cdonor_gain0.5500
3:122415820:AAAG:Adonor_gain0.5300
3:122415607:C:CTacceptor_gain0.5000

AlphaMissense

2152 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:122415258:A:GW91R0.999
3:122415258:A:TW91R0.999
3:122415355:A:CS58R0.999
3:122415355:A:TS58R0.999
3:122415357:T:GS58R0.999
3:122414949:A:GW194R0.998
3:122414949:A:TW194R0.998
3:122414971:G:CS186R0.998
3:122414971:G:TS186R0.998
3:122414973:T:GS186R0.998
3:122415075:A:GW152R0.998
3:122415075:A:TW152R0.998
3:122415101:C:TG143E0.998
3:122415104:G:CS142W0.998
3:122414979:A:GS184P0.997
3:122415020:A:TV170D0.997
3:122415099:A:GS144P0.997
3:122415105:A:GS142P0.997
3:122415225:A:GS102P0.997
3:122415231:A:GS100P0.997
3:122414685:A:GW282R0.996
3:122414685:A:TW282R0.996
3:122414852:A:GL226P0.996
3:122414947:C:AW194C0.996
3:122414947:C:GW194C0.996
3:122415073:C:AW152C0.996
3:122415073:C:GW152C0.996
3:122415201:A:GW110R0.996
3:122415201:A:TW110R0.996
3:122415227:G:TA101D0.996

dbSNP variants (sampled 300 via entrez): RS1000041500 (3:122411725 T>G), RS1000063567 (3:122413227 T>G), RS1000742397 (3:122411861 T>C), RS1000869933 (3:122417419 A>G), RS1001174774 (3:122411511 A>G), RS1001302243 (3:122417146 G>T), RS1001354609 (3:122416848 G>A,C,T), RS1001418364 (3:122416586 T>A,G), RS1002915388 (3:122412268 A>C), RS1003763622 (3:122415416 A>T), RS1003788066 (3:122413796 C>T), RS1003949954 (3:122413653 G>A), RS1004385373 (3:122413827 T>A), RS1004912443 (3:122415190 T>C), RS1005978996 (3:122413741 G>A)

Disease associations

OMIM: gene MIM:621240 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST000769_5Calcium levels2.000000e-22

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004838calcium measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Formaldehydeincreases expression, decreases expression2
Cyclosporineincreases expression2
aristolochic acid Idecreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
GSK-J4decreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
butyraldehydedecreases expression1
avobenzonedecreases expression1
di-n-butylphosphoric acidaffects expression1
tebuconazoledecreases expression1
CGP 52608affects binding, increases reaction1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideaffects cotreatment, increases expression1
Acetaminophenincreases expression1
Carbamazepineaffects expression1
Drugs, Chinese Herbalincreases expression1
Endosulfanincreases expression1
Methyl Methanesulfonateincreases expression1
Naphthoquinonesincreases expression1
Potassium Chloridedecreases expression, decreases response to substance1
Quercetindecreases expression1
Seleniumdecreases expression1
Silicon Dioxidedecreases expression1
Sodium Dodecyl Sulfatedecreases expression1
Tetrachlorodibenzodioxinaffects cotreatment, increases expression1
Dronabinoldecreases response to substance, decreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.